CD22-Binding Peptides Derived from Anti-CD22 Ligand Blocking Antibodies Retain the Targeting and Cell Killing Properties of the Parent Antibodies and May Serve as a Drug Delivery Vehicle

Authors

• David, Pearson
• Robert T., O’donnell
• Miguel, Cerejo
• Hayes C., Mcknight
• Xiaobing, Wang
• Jan, Mařik
• Kit S. Lam
• Joseph M., Tuscano

Type

Published Article

Journal

International Journal of Peptide Research and Therapeutics

Publisher

Springer-Verlag

Volume

14

Issue

3

Pages

237–246

Identifiers

DOI: 10.1007/s10989-008-9138-z

Source

Kit Lam Lab

License

Unknown